Zhejiang Jiuzhou Pharmaceutical Hits Day High with Strong 4.29% Surge

Zhejiang Jiuzhou Pharmaceutical Co., Ltd. has experienced a notable increase in its stock price, rising by 4.29% on July 20, 2026. The stock reached an intraday high of CNY 15.08, reflecting a strong performance compared to the broader market, as the China Shanghai Composite index only gained 0.85% on the same day. Over the past week, Zhejiang Jiuzhou has shown a positive trend, with a 3.01% increase, while the Shanghai Composite declined by 3.0%. In the month leading up to this day, the stock has surged by 14.94%, contrasting sharply with the index's drop of 7.19%. However, the company has faced challenges over the longer term, with a year-to-date decline of 15.75% and a three-year drop of 39.07%. Financially, Zhejiang Jiuzhou maintains a return on equity of 7.28% and a price-to-book ratio of 1.23, indicating a relatively attractive valuation. The company also offers a dividend yield of 4.10%, appealing to income-focused investors. Overall, the stock's recent performance highlights its resilience in a fluctuating market environment.